Dimethylamine

Dimethylamine

SCHEMBL8512417

C=C(C)C(=O)NCCC.CNC.CNC.Cl

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dimethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 known ✓ P03956 1/20 0.39
GAA known ✓ P10253 1/20 0.35
ACHE known ✓ P22303 1/20 0.32
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
EPHX1 P07099 4/20 0.38
PAOX Q6QHF9 1/20 0.36
MCL1 Q07820 1/20 0.36
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TGFBR1 P36897 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PLA2G2A P14555 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL10790993 1.00 MMP1 (0.39) MMP1MMP2MMP3MMP9EPHX1
Dimethylamine SCHEMBL42843 0.98 MMP1 (0.40) MMP1MMP2MMP3MMP9EPHX1
Dimethylamine SCHEMBL8509082 0.96 MMP1 (0.39) MMP1MMP2MMP3MMP9EPHX1
Dimethylamine SCHEMBL8511788 0.96 MMP1 (0.39) MMP1MMP2MMP3MMP9EPHX1
Hydrochloric Acid SCHEMBL3148805 0.96 MMP1 (0.41) MMP1MMP2MMP3MMP9EPHX1
Dimethylamine SCHEMBL15902173 0.94 MMP1 (0.38) MMP1MMP2MMP3MMP9EPHX1
Hydrochloric Acid SCHEMBL28010702 0.93 MMP1 (0.40) MMP1MMP2MMP3MMP9EPHX1
SCHEMBL149370 0.93
Dimethylamine SCHEMBL9572414 0.92 MMP1 (0.36) MMP1MMP2MMP3MMP9EPHX1
Methylamine SCHEMBL6561969 0.91 MMP1 (0.39) MMP1MMP2MMP3MMP9EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10337282-B2 Methods and compositions for reducing water production in fractures or voids in subterranean formations HALLIBURTON ENERGY SERVICES, INC. (US) 2019-07-02 US disclosed
US-20180022982-A1 METHODS AND COMPOSITIONS FOR REDUCING WATER PRODUCTION IN FRACTURES OR VOIDS IN SUBTERRANEAN FORMATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2018-01-25 US disclosed
WO-2016153519-A1 METHODS AND COMPOSITIONS FOR REDUCING WATER PRODUCTION IN FRACTURES OR VOIDS IN SUBTERRANEAN FORMATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2016-09-29 WO disclosed
US-8991495-B2 Methods for protecting a hydrocarbon-producing zone of a subterranean formation using a relative permeability modifier HALLIBURTON ENERGY SERVICES, INC. (US) 2015-03-31 US disclosed
WO-2013173600-A2 METHODS FOR PROTECTING A HYDROCARBON-PRODUCING ZONE OF A SUBTERRANEAN FORMATION USING A RELATIVE PERMEABILITY MODIFIER HALLIBURTON ENERGY SERVICES, INC. (US) 2013-11-21 WO disclosed
US-20130306314-A1 Methods for Protecting a Hydrocarbon-Producing Zone of a Subterranean Formation Using a Relative Permeability Modifier HALLIBURTON ENERGY SERVICES, INC. (US) 2013-11-21 US disclosed
US-8470746-B2 Methods relating to the stabilization of hydrophobically modified hydrophilic polymer treatment fluids under alkaline conditions HALLIBURTON ENERGY SERVICES, INC. (US) 2013-06-25 US disclosed
US-20120135895-A1 Compositions and Methods Relating to the Stabilization of Hydrophobically Modified Hydrophilic Polymer Treatment Fluids Under Alkaline Conditions HALLIBURTON ENERGY SERVICES, INC. (US) 2012-05-31 US disclosed